Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0T5AW
|
|||
Former ID |
DIB004852
|
|||
Drug Name |
Desoxypeganine
|
|||
Synonyms |
Alcoholism therapy, HF Arzneimittelforschung; Desoxypeganine, HF Arzneimittelforschung
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Alcohol dependence [ICD-11: 6C40.2; ICD-10: F10.2; ICD-9: 303] | Phase 1 | [1] | |
Company |
HF Arzneimittelforschung GmbH & Co KG
|
|||
Structure |
Download2D MOL |
|||
Formula |
C11H12N2
|
|||
Canonical SMILES |
C1CC2=NC3=CC=CC=C3CN2C1
|
|||
InChI |
1S/C11H12N2/c1-2-5-10-9(4-1)8-13-7-3-6-11(13)12-10/h1-2,4-5H,3,6-8H2
|
|||
InChIKey |
WUFQLZTXIWKION-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 495-59-0
|
|||
PubChem Compound ID | ||||
ChEBI ID |
CHEBI:4428
|
References | Top | |||
---|---|---|---|---|
REF 1 | Phase I clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: tolerance and pharmacokinetics study of escalating single oral doses. Methods Find Exp Clin Pharmacol. 2008 Mar;30(2):141-7. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.